We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




3D Network Structures Improve Survival of Transplanted Stem Cell-Derived Neurons

By LabMedica International staff writers
Posted on 27 Mar 2016
Print article
Image: Reprogrammed human neurons grown on 3D scaffolds (within the white dash line) and transplanted onto brain tissue (red) extended out (yellow lines) and integrated (Photo courtesy of Neal K. Bennett, Moghe Laboratory, Rutgers University).
Image: Reprogrammed human neurons grown on 3D scaffolds (within the white dash line) and transplanted onto brain tissue (red) extended out (yellow lines) and integrated (Photo courtesy of Neal K. Bennett, Moghe Laboratory, Rutgers University).
Neurological disease researchers have developed a method for treating neurodegenerative diseases such as Parkinson's by transplanting three-dimensional (3D) networks of stem cell-derived neurons into the damaged brain tissue.

Cell replacement therapy using human pluripotent stem cell-derived neurons has the potential to correct neurodegenerative damage and central nervous system injuries, but transplantation of dissociated and spatially disorganized neurons portends poor cell survival and incomplete functional development.

Investigators at Rutgers University (Piscataway, NJ, USA) and Stanford University (Palo Alto, CA, USA) recently described the design of three-dimensional scaffolds based on tunable electrospun microfibrous polymeric substrates. These scaffolds promoted in situ stem cell neuronal reprogramming, neural network establishment, and supported neuronal engraftment into the brain.

The investigators reported in the March 17, 2016, online edition of the journal Nature Communications that they had successfully grafted scaffold-supported, reprogrammed neuronal networks into organotypic hippocampal brain slices. This approach yielded an approximately 3.5-fold improvement in neurite outgrowth and increased action potential firing relative to injected isolated cells. Transplantation of scaffold-supported neuronal networks into mouse brain striatum improved survival by about 38-fold at the injection site relative to injected isolated cells, and allowed delivery of multiple neuronal subtypes.

"If you can transplant cells in a way that mimics how these cells are already configured in the brain, then you are one step closer to getting the brain to communicate with the cells that you are now transplanting," said senior author Dr. Prabhas V. Moghe, professor of biomedical, chemical, and biochemical engineering at Rutgers University. "In this work, we have done that by providing cues for neurons to rapidly network in three dimensions."

Related Links:

Rutgers University
Stanford University


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The new blood test identifies key biomarkers of osteoarthritis (Photo courtesy of Shutterstock)

Blood Test Predicts Knee Osteoarthritis Eight Years Before Signs Appears On X-Rays

Osteoarthritis (OA) is the most prevalent form of arthritis, impacting millions worldwide and resulting in significant economic and social costs. Although no cure exists currently, the effectiveness of... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Sampler device could revolutionize sample collection for diagnostic tests (Photo courtesy of ReadyGo Diagnostics)

First of Its Kind Universal Tool to Revolutionize Sample Collection for Diagnostic Tests

The COVID pandemic has dramatically reshaped the perception of diagnostics. Post the pandemic, a groundbreaking device that combines sample collection and processing into a single, easy-to-use disposable... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.